Effector and potential immunoregulatory roles of mast cells in IgE-associated acquired immune responses

Current Opinion in Immunology

Volumn 18, Issue 6, 2006, Pages 751-760

  Grimbaldeston, Michele A ^a   Metz, Martin ^a   Yu, Mang ^a   Tsai, Mindy ^a   Galli, Stephen J ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; IMMUNOGLOBULIN E;

ALLERGIC DISEASE; ANTIGEN SPECIFICITY; AUTOIMMUNE DISEASE; BASOPHIL; CELL FUNCTION; CELLULAR IMMUNITY; CYTOLOGY; EFFECTOR CELL; HUMAN; HYPERSENSITIVITY REACTION; IMMEDIATE TYPE HYPERSENSITIVITY; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; INFLAMMATION; INFLAMMATORY CELL; KNOCKOUT MOUSE; MAST CELL; NONHUMAN; REVIEW; SENSITIZATION;

ANIMALS; HUMANS; HYPERSENSITIVITY, IMMEDIATE; IMMUNOGLOBULIN E; MAST CELLS; MICE; SIGNAL TRANSDUCTION;

EID: 33750423124     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coi.2006.09.011     Document Type: Review

References (83)

1. Metcalfe D.D., Baram D., and Mekori Y.A. Mast cells. Physiol Rev 77 (1997) 1033-1079
2. Marone G., Triggiani M., Genovese A., and Paulis A.D. Role of human mast cells and basophils in bronchial asthma. Adv Immunol 88 (2005) 97-160
3. Galli S.J., Kalesnikoff J., Grimbaldeston M.A., Piliponsky A.M., Williams C.M.M., and Tsai M. Mast cells as "tunable" effector and immunoregulatory cells: recent advances. Annu Rev Immunol 23 (2005) 749-786
4. Galli S.J., Nakae S., and Tsai M. Mast cells in the development of adaptive immune responses. Nat Immunol 6 (2005) 135-142
5. Kitamura Y. Heterogeneity of mast cells and phenotypic change between subpopulations. Annu Rev Immunol 7 (1989) 59-76
6. Chen C.-C., Grimbaldeston M.A., Tsai M., Weissman I.L., and Galli S.J. Identification of mast cell progenitors in adult mice. Proc Natl Acad Sci USA 102 (2005) 11408-11413
7. Arinobu Y., Iwasaki H., Gurish M.F., Mizuno S., Shigematsu H., Ozawa H., Tenen D.G., Austen K.F., and Akashi K. Developmental checkpoints of the basophil/mast cell lineages in adult murine hematopoiesis. Proc Natl Acad Sci USA 102 (2005) 18105-18110
8. Kawakami T., and Galli S.J. Regulation of mast-cell and basophil function and survival by IgE. Nat Rev Immunol 2 (2002) 773-786
9. Reg cells might have contributed to the development and/or survival of mast cells in the skin allografts.
10. Rivera J., and Gilfillan A.M. Molecular regulation of mast cell activation. J Allergy Clin Immunol 117 (2006) 1214-1225
11. Kinet J.-P. The high-affinity IgE receptor (FcεRI): from physiology to pathology. Annu Rev Immunol 17 (1999) 931-972
12. Marshall J.S. Mast-cell responses to pathogens. Nat Rev Immunol 4 (2004) 787-799
13. Mekori Y.A., and Metcalfe D.D. Mast cell-T cell interactions. J Allergy Clin Immunol 104 (1999) 517-523
14. Robbie-Ryan M., Tanzola M.B., Secor V.H., and Brown M.A. Cutting edge: both activating and inhibitory Fc receptors expressed on mast cells regulate experimental allergic encephalomyelitis disease severity. J Immunol 170 (2003) 1630-1634
15. Kashiwakura J., Yokoi H., Saito H., and Okayama Y. T cell proliferation by direct cross-talk between OX40 ligand on human mast cells and OX40 on human T cells: comparison of gene expression profiles between human tonsillar and lung-cultured mast cells. J Immunol 173 (2004) 5247-5257
16. + T cells that had been suboptimally stimulated through the CD3-TCR complex, or both cell populations. These experiments showed that mouse mast cells and mast cell-derived TNF enhanced the development of local inflammation in this passive transfer model of cutaneous inflammation in vivo.
17. Nakae S., Suto H., Iikura M., Kakurai M., Sedgwick J.D., Tsai M., and Galli S.J. Mast cells enhance T cell activation: importance of mast cell costimulatory molecules and secreted TNF. J Immunol 176 (2006) 2238-2248
18. Gregory G.D., Raju S.S., Winandy S., and Brown M.A. Mast cell IL-4 expression is regulated by Ikaros and influences encephalitogenic Th1 responses in EAE. J Clin Invest 116 (2006) 1327-1336. This study used mast cell knock-in mice and other lines of evidence to show that mast cell-derived IL-4 can promote Th1 cell development in a mouse model of experimental allergic encephalomyelitis. The results presented suggest that the site and timing of IL-4 expression, as well as the genetic background of the mice used, can contribute to the heterogeneity of the T helper response elicited in this model of autoimmunity.
19. v mice. Evidence that cultured mast cells can give rise to both connective tissue type and mucosal mast cells. J Exp Med 162 (1985) 1025-1043
20. Tsai M., Tam S.-Y., Wedemeyer J., and Galli S.J. Mast cells derived from embryonic stem cells: a model system for studying the effects of genetic manipulations on mast cell development, phenotype, and function in vitro and in vivo. Int J Hematol 75 (2002) 345-349
21. W-sh sash mice. Clin Exp Allergy 35 (2005) 82-88
22. W-sh/W-sh mice as a model for investigating mast cell biology in vivo. Am J Pathol 167 (2005) 835-848
23. sh) at the W-locus and a spontaneous recessive lethal in mice. Genet Res 39 (1982) 315-322
24. Bryce P.J., Miller M.L., Miyajima I., Tsai M., Galli S.J., and Oettgen H.C. Immune sensitization in the skin is enhanced by antigen-independent effects of IgE. Immunity 20 (2004) 381-392
25. Matsuda K., Piliponsky A.M., Iikura M., Nakae S., Wang E.W., Dutta S.M., Kawakami T., Tsai M., and Galli S.J. Monomeric IgE enhances human mast cell chemokine production: IL-4 augments and dexamethasone suppresses the response. J Allergy Clin Immunol 116 (2005) 1357-1363
26. Suto H., Nakae S., Kakurai M., Sedgwick J.D., Tsai M., and Galli S.J. Mast cell-associated TNF promotes dendritic cell migration. J Immunol 176 (2006) 4102-4112
27. -/- BMCMCs, into mast cell-deficient mice permitted such mice to express levels of eosinophil infiltration after OVA challenge that were similar to those in WT mice. Although these findings are interesting, immunization with OVA was begun only two days after adoptive transfer of the BMCMCs, which is too short an interval for the cells to migrate to their ultimate anatomical locations or to acquire a more mature phenotype. Therefore, it will be important to investigate whether similar findings can be obtained in mast cell-deficient mice that have undergone mast cell engraftment for longer intervals (e.g. 8-12 weeks) before immunization.
28. Cumberbatch M., Dearman R.J., Griffiths C.E., and Kimber I. Langerhans cell migration. Clin Exp Dermatol 25 (2000) 413-418
29. Kaser A., Dunzendorfer S., Offner F.A., Ryan T., Schwabegger A., Cruikshank W.W., Wiedermann C.J., and Tilg H. A role for IL-16 in the cross-talk between dendritic cells and T cells. J Immunol 163 (1999) 3232-3238
30. Cumberbatch M., Dearman R.J., Antonopoulos C., Groves R.W., and Kimber I. Interleukin (IL)-18 induces Langerhans cell migration by a tumour necrosis factor-α- and IL-1β-dependent mechanism. Immunology 102 (2001) 323-330
31. 2-EP4 signaling initiates skin immune responses by promoting migration and maturation of Langerhans cells. Nat Med 9 (2003) 744-749
32. 2, promote type 2 cytokine production in maturing human naïve T helper cells. J Immunol 159 (1997) 28-35
33. 2 inhibits the production of interleukin-12 in murine dendritic cells through multiple signaling pathways. Eur J Immunol 33 (2003) 889-898
34. Mazzoni A., Young H.A., Spitzer J.H., Visintin A., and Segal D.M. Histamine regulates cytokine production in maturing dendritic cells, resulting in altered T cell polarization. J Clin Invest 108 (2001) 1865-1873
35. Caron G., Delneste Y., Roelandts E., Duez C., Bonnefoy J.Y., Pestel J., and Jeannin P. Histamine polarizes human dendritic cells into Th2 cell-promoting effector dendritic cells. J Immunol 167 (2001) 3682-3686
36. Depinay N., Hacini F., Beghdadi W., Peronet R., and Mecheri S. Mast cell-dependent down-regulation of antigen-specific immune responses by mosquito bites. J Immunol 176 (2006) 4141-4146. This study employed mast cell knock-in mice to demonstrate that mice that had been bitten by mosquitoes before subcutaneous sensitization to OVA (at another skin site) exhibited a mast cell-dependent suppression of antigen-specific DTH responses to OVA when they were later challenged with OVA at the same site as the mosquito bite. The mast cell-dependent immunoregulatory mechanism in this model remains to be defined, including identification of the extent to which key effects occur in the sensitization versus the elicitation phase of the DTH response. However, the authors detected enhanced levels of IL-10 mRNA in draining LNs 24 h after the mosquito bite. Moreover, administration of anti-IL-10 antibody before sensitization with OVA restored the magnitude of DTH responses, as well as levels of skin and LN IFN-γ mRNA and protein, in mosquito-bitten mice to values similar to those observed in control unbitten mice.
37. Hart P.H., Grimbaldeston M.A., Swift G.J., Jaksic A., Noonan F.P., and Finlay-Jones J.J. Dermal mast cells determine susceptibility to ultraviolet B-induced systemic suppression of contact hypersensitivity responses in mice. J Exp Med 187 (1998) 2045-2053
38. Jutel M., Watanabe T., Klunker S., Akdis M., Thomet O.A., Malolepszy J., Zak-Nejmark T., Koga R., Kobayashi T., Blaser K., et al. Histamine regulates T-cell and antibody responses by differential expression of H1 and H2 receptors. Nature 413 (2001) 420-425
39. Finkelman F.D., Rothenberg M.E., Brandt E.B., Morris S.C., and Strait R.T. Molecular mechanisms of anaphylaxis: lessons from studies with murine models. J Allergy Clin Immunol 115 (2005) 449-457
40. 1-dependent passive anaphylaxis. J Clin Invest 99 (1997) 901-914
41. Dombrowicz D., Flamand V., Miyajima I., Ravetch J.V., Galli S.J., and Kinet J.-P. Absence of FcεRIα chain results in upregulation of FcγRIII-dependent mast cell degranulation and anaphylaxis. Evidence of competition between FcεRI and FcγRIII for limiting amounts of FcR β and γ chains. J Clin Invest 99 (1997) 915-925
42. Strait R.T., Morris S.C., Yang M., Qu X.W., and Finkelman F.D. Pathways of anaphylaxis in the mouse. J Allergy Clin Immunol 109 (2002) 658-668
43. Mukai K., Matsuoka K., Taya C., Suzuki H., Yokozeki H., Nishioka K., Hirokawa K., Etori M., Yamashita M., Kubota T., et al. Basophils play a critical role in the development of IgE-mediated chronic allergic inflammation independently of T cells and mast cells. Immunity 23 (2005) 191-202. This study showed that, in mice bearing antigen-specific IgE that were challenged with a single subcutaneous injection of the specific multivalent antigen, mast cells were essential for IgE-dependent immediate and late phase ear-swelling responses. However, it showed that they were not essential for the delayed-onset ear-swelling response that was characterized by persistent inflammation and extensive eosinophil infiltration. Transfer of FcεRI-expressing basophils into FcεRI-deficient mice restored the ability to develop the delayed-onset phase of such allergic inflammation. This finding, together with other lines of evidence in this study, supports the conclusion that in this model basophils played an important role, independent of T cells and mast cells, in the development of IgE-dependent chronic allergic inflammation.
44. 125I-fibrin deposition in IgE-dependent immediate hypersensitivity reactions in mouse skin. Demonstration of the role of mast cells using genetically mast cell-deficient mice locally reconstituted with cultured mast cells. J Immunol 139 (1987) 2605-2614
45. Choi I.H., Shin Y.M., Park J.S., Lee M.S., Han E.H., Chai O.H., Im S.Y., Ha T.Y., and Lee H.K. Immunoglobulin E-dependent active fatal anaphylaxis in mast cell-deficient mice. J Exp Med 188 (1998) 1587-1592
46. Williams C.M.M., and Galli S.J. The diverse potential effector and immunoregulatory roles of mast cells in allergic disease. J Allergy Clin Immunol 105 (2000) 847-859
47. Benoist C., and Mathis D. Mast cells in autoimmune disease. Nature 420 (2002) 875-878
48. Kay A.B. Allergy and allergic diseases. First of two parts. N Engl J Med 344 (2001) 30-37
49. Wershil B.K., Wang Z.-S., Gordon J.R., and Galli S.J. Recruitment of neutrophils during IgE-dependent cutaneous late phase reactions in the mouse is mast cell-dependent. Partial inhibition of the reaction with antiserum against tumor necrosis factor-alpha. J Clin Invest 87 (1991) 446-453
50. Furuta G.T., Schmidt-Choudhury A., Wang M.Y., Wang Z.-S., Lu L., Furlano R.I., and Wershil B.K. Mast cell-dependent tumor necrosis factor alpha production participates in allergic gastric inflammation in mice. Gastroenterology 113 (1997) 1560-1569
51. Jawdat D.M., Albert E.J., Rowden G., Haidl I.D., and Marshall J.S. IgE-mediated mast cell activation induces Langerhans cell migration in vivo. J Immunol 173 (2004) 5275-5282
52. Williams C.M.M., and Galli S.J. Mast cells can amplify airway reactivity and features of chronic inflammation in an asthma model in mice. J Exp Med 192 (2000) 455-462
53. Taube C., Wei X., Swasey C.H., Joetham A., Zarini S., Lively T., Takeda K., Loader J., Miyahara N., Kodama T., et al. Mast cells, FcεRI, and IL-13 are required for development of airway hyperresponsiveness after aerosolized allergen exposure in the absence of adjuvant. J Immunol 172 (2004) 6398-6406
54. 1-antigen immune complexes). For example, the antigen-dependent increase in numbers of lung mast cells that occurred in this model appeared to be entirely dependent on mast cell expression of FcRγ, whereas mast cell-dependent but FcRγ-independent mechanisms significantly contributed to the antigen-dependent increases noted in epithelial goblet cells and in levels of mRNA for Muc5ac and Muc5b - genes that encode mucin proteins.
55. Miyazaki D., Nakamura T., Toda M., Cheung-Chau K.W., Richardson R.M., and Ono S.J. Macrophage inflammatory protein-1α as a costimulatory signal for mast cell-mediated immediate hypersensitivity reactions. J Clin Invest 115 (2005) 434-442
56. Gerard N.P., and Gerard C. Complement in allergy and asthma. Curr Opin Immunol 14 (2002) 705-708
57. Zaidi A.K., Amrani Y., Panettieri R.A., and Ali H. Response to C3a, mast cells, and asthma. FASEB J 20 (2006) 199
58. Miller H.R. Mucosal mast cells and the allergic response against nematode parasites. Vet Immunol Immunopathol 54 (1996) 331-336
59. Matsuda H., Watanabe N., Kiso Y., Hirota S., Ushio H., Kannan Y., Azuma M., Koyama H., and Kitamura Y. Necessity of IgE antibodies and mast cells for manifestation of resistance against larval Haemaphysalis longicornis ticks in mice. J Immunol 144 (1990) 259-262
60. Lantz C.S., Boesiger J., Song C.H., Mach N., Kobayashi T., Mulligan R.C., Nawa Y., Dranoff G., and Galli S.J. Role for interleukin-3 in mast-cell and basophil development and in immunity to parasites. Nature 392 (1998) 90-93
61. Secor V.H., Secor W.E., Gutekunst C.A., and Brown M.A. Mast cells are essential for early onset and severe disease in a murine model of multiple sclerosis. J Exp Med 191 (2000) 813-822
62. Chen R., Ning G., Zhao M.L., Fleming M.G., Diaz L.A., Werb Z., and Liu Z. Mast cells play a key role in neutrophil recruitment in experimental bullous pemphigoid. J Clin Invest 108 (2001) 1151-1158
63. Lee D.M., Friend D.S., Gurish M.F., Benoist C., Mathis D., and Brenner M.B. Mast cells: a cellular link between autoantibodies and inflammatory arthritis. Science 297 (2002) 1689-1692
64. Gregory G.D., and Brown M.A. Mast cells in allergy and autoimmunity: implications for adaptive immunity. Methods Mol Biol 315 (2006) 35-50
65. Pedotti R., De Voss J.J., Steinman L., and Galli S.J. Involvement of both 'allergic' and 'autoimmune' mechanisms in EAE, MS and other autoimmune diseases. Trends Immunol 24 (2003) 479-484
66. d mast cell-deficient mice. J Immunol 131 (1983) 2687-2694
67. Galli S.J., and Hammel I. Unequivocal delayed hypersensitivity in mast cell-deficient and beige mice. Science 226 (1984) 710-713
68. Biedermann T., Kneilling M., Mailhammer R., Maier K., Sander C.A., Kollias G., Kunkel S.L., Hultner L., and Rocken M. Mast cells control neutrophil recruitment during T cell-mediated delayed-type hypersensitivity reactions through tumor necrosis factor and macrophage inflammatory protein 2. J Exp Med 192 (2000) 1441-1452
69. Kakurai M, Monteforte R, Suto H, Tsai M, Nakae S, Galli SJ: Mast cell-derived TNF promotes nerve fiber elongation in the skin during contact hypersensitivity in mice. Am J Pathol 2006, in press.
70. Kraneveld A.D., van der Kleij H.P., Kool M., van Houwelingen A.H., Weitenberg A.C., Redegeld F.A., and Nijkamp F.P. Key role for mast cells in nonatopic asthma. J Immunol 169 (2002) 2044-2053
71. Rijnierse A., Koster A.S., Nijkamp F.P., and Kraneveld A.D. Critical role for mast cells in the pathogenesis of 2,4-dinitrobenzene-induced murine colonic hypersensitivity reaction. J Immunol 176 (2006) 4375-4384. In a mouse model of hapten-induced inflammatory bowel disease studied in mast cell knock-in mice, mast cells were shown to be required for recruitment of neutrophils, development of elevated levels of mast cell protease-1 in the plasma, increased colonic vascular permeability, hypertrophy of colonic lymphoid follicles and the occurrence of diarrhoea.
72. Brown S.J., Galli S.J., Gleich G.J., and Askenase P.W. Ablation of immunity to Amblyomma americanum by anti-basophil serum: cooperation between basophils and eosinophils in expression of immunity to ectoparasites (ticks) in guinea pigs. J Immunol 129 (1982) 790-796
73. Steeves E.B.T., and Allen J.R. Basophils in skin reactions of mast cell-deficient mice infested with Dermacentor variabilis. Int J Parasitol 20 (1990) 655-667
74. Gauchat J.-F., Henchoz S., Mazzei G., Aubry J.-P., Brunner T., Blasey H., Life P., Talabot D., Flores-Romo L., Thompson J., et al. Induction of human IgE synthesis in B cells by mast cells and basophils. Nature 365 (1993) 340-343
75. Pawankar R., Okuda M., Yssel H., Okumura K., and Ra C. Nasal mast cells in perennial allergic rhinitics exhibit increased expression of the FcεRI, CD40L, IL-4, and IL-13, and can induce IgE synthesis in B cells. J Clin Invest 99 (1997) 1492-1499
76. Pawankar R., and Ra C. IgE-FcεRI-mast cell axis in the allergic cycle. Clin Exp Allergy 28 (1998) 6-14
77. Lomintzer R., Lanner A., and Rabson A.R. Low specific IgE, IgG and lymphocyte reactivity in a group of patients developing anaphylaxis following a honey-bee sting. Clin Allergy 18 (1988) 39-44
78. Golden D.B.K. Insect allergy in children. Curr Opin Allergy Clin Immunol 6 (2006) 289-293
79. Saxon A., Diaz-Sanchez D., and Zhang K. The allergic response in host defence. In: Edited by Rich R.R., Fleisher T.A., Shearer W.T., Kotzin B.L., and Schroeder H.W. (Eds). Clinical Immunology: Principles and Practice. edn 2 (2001), Mosby International Ltd 45.1-45.11
80. Vercelli D. Genetic regulation of IgE responses: Achilles and the tortoise. J Allergy Clin Immunol 116 (2005) 60-64
81. Katz H. Inhibition of anaphylactic inflammation by the gp49B1 receptor on mast cells. Mol Immunol 38 (2001) 1301-1305
82. Zhu D., Kepley C.L., Zhang K., Terada T., Yamada T., and Saxon A. A chimeric human-cat fusion protein blocks cat-induced allergy. Nat Med 11 (2005) 446-449. The authors developed and tested a new approach for the treatment of allergic diseases that is based on a chimeric fusion protein comprised of truncated human IgG Fcγ1 plus the major cat (Felis domesticus) allergen Fel d1. The Fcγ-Fel d1 protein did not by itself induce mediator release from FcεRI-bearing effector cells that had been sensitized with IgE specific for Fel d1, but instead induced a dose-dependent inhibition of Fel d1-driven IgE-mediated histamine release in vitro from basophils of patients with cat allergy and from IgE-sensitized human umbilical cord blood-derived mast cells. In vivo, the Fcγ-Fel d1 protein also reduced the intensity of responses to allergen in both human FcεRIα-expressing transgenic mice that had been passively immunized intravenously with Fel d1-specific IgE and challenged 24 h later with purified Fel d1, and in BALB/c mice that had been actively immunized with Fel d1 and then challenged several days later with the same antigen. The authors presented biochemical evidence suggesting that this treatment works by inducing the simultaneous engagement, on FcεRI-bearing effector cells, of the FcεRI and the negative regulatory receptor FcγRIIb, resulting in diminished Syk phosphorylation and downstream signaling events in these cells upon their exposure to Fel d1 allergen.
83. Strait R.T., Morris S.C., and Finkelman F.D. IgG-blocking antibodies inhibit IgE-mediated anaphylaxis in vivo through both antigen interception and FcγRIIb cross-linking. J Clin Invest 116 (2006) 833-841. This study provides novel in vivo evidence that, under some circumstances, production of allergen-specific IgG can block IgE-mediated anaphylaxis without inducing immune complex- and FcγRIII-mediated anaphylaxis. The authors show that complete suppression of IgE-mediated anaphylaxis by IgG can occur only when the concentration of IgG antibody is high and the challenge dose of allergen is low, and that the propensity of an allergen to induce either IgE- or FcγRIII-mediated anaphylaxis is inversely proportional to the allergen epitope density. Moreover, they show that two mechanisms can contribute to the ability of IgG 'blocking antibodies' to suppress IgE-dependent anaphylaxis: first, interception of allergens before they can reach and cross-link mast cell FcεRI-associated IgE, and, second, the more indirect mechanism of cross-linking, on effector cells, FcεRI to the inhibitory IgG receptor FcγRIIb.